egreenews

THOUSAND OAKS, Calif., Nov. 25, 2024 /PRNewswire/ — Capsida Biotherapeutics (“Capsida”), a leading fully integrated next-generation gene therapy company developing treatments for rare and common diseases across all ages, today announced that the company will present […]

CAP-003 achieved best-in-class GCase increases in NHPs exceeding levels needed for normalizing activity in patients Brainwide RNA expression greater than 200-fold higher than AAV9, with significant detargeting of liver and DRGs with proprietary engineered capsid […]